Patricia F Coogan1, Laura F White, Jeffrey Yu, Richard T Burnett, Edmund Seto, Robert D Brook, Julie R Palmer, Lynn Rosenberg, Michael Jerrett. 1. aSlone Epidemiology Center at Boston University, Boston, MA; bDepartment of Biostatistics, Boston University School of Public Health, Boston, MA; cHealthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Canada; dDepartment of Occupational and Environmental Health Sciences, University of Washington School of Public Health, Seattle, WA; eDivision of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, MI; and fDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, CA.
Abstract
BACKGROUND: Clinical studies have shown that exposure to fine particulate matter (PM2.5) can increase insulin resistance and blood pressure. The epidemiologic evidence for an association of PM2.5 exposure with the incidence of type 2 diabetes or hypertension is inconsistent. Even a modest association would have great public health importance given the ubiquity of exposure and high prevalence of the conditions. METHODS: We used Cox proportional hazards models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident type 2 diabetes and hypertension associated with exposure to PM2.5 in a large cohort of African American women living in 56 metropolitan areas across the US, using data from the Black Women's Health Study. Pollutant levels were estimated at all residential locations over follow-up with a hybrid model incorporating land use regression and Bayesian Maximum Entropy techniques. RESULTS: During 1995 to 2011, 4,387 cases of diabetes and 9,570 cases of hypertension occurred. In models controlling for age, questionnaire cycle, and metro area, there were positive associations with diabetes (HR = 1.13, 95% CI = 1.04, 1.24) and hypertension (HR = 1.06, 95% CI = 1.00, 1.12) per interquartile range of PM2.5 (2.9 μg/m). Multivariable HRs, however, were 0.99 (95% CI = 0.90, 1.09) for diabetes and 0.99 (95% CI = 0.93, 1.06) for hypertension. CONCLUSIONS: Our results provide little support for an association of PM2.5 with diabetes or hypertension incidence.
BACKGROUND: Clinical studies have shown that exposure to fine particulate matter (PM2.5) can increase insulin resistance and blood pressure. The epidemiologic evidence for an association of PM2.5 exposure with the incidence of type 2 diabetes or hypertension is inconsistent. Even a modest association would have great public health importance given the ubiquity of exposure and high prevalence of the conditions. METHODS: We used Cox proportional hazards models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident type 2 diabetes and hypertension associated with exposure to PM2.5 in a large cohort of African American women living in 56 metropolitan areas across the US, using data from the Black Women's Health Study. Pollutant levels were estimated at all residential locations over follow-up with a hybrid model incorporating land use regression and Bayesian Maximum Entropy techniques. RESULTS: During 1995 to 2011, 4,387 cases of diabetes and 9,570 cases of hypertension occurred. In models controlling for age, questionnaire cycle, and metro area, there were positive associations with diabetes (HR = 1.13, 95% CI = 1.04, 1.24) and hypertension (HR = 1.06, 95% CI = 1.00, 1.12) per interquartile range of PM2.5 (2.9 μg/m). Multivariable HRs, however, were 0.99 (95% CI = 0.90, 1.09) for diabetes and 0.99 (95% CI = 0.93, 1.06) for hypertension. CONCLUSIONS: Our results provide little support for an association of PM2.5 with diabetes or hypertension incidence.
Authors: Joel Schwartz; Stacey E Alexeeff; Irina Mordukhovich; Alexandros Gryparis; Pantel Vokonas; Helen Suh; Brent A Coull Journal: Occup Environ Med Date: 2012-03-01 Impact factor: 4.402
Authors: Patricia F Coogan; Laura F White; Michael Jerrett; Robert D Brook; Jason G Su; Edmund Seto; Richard Burnett; Julie R Palmer; Lynn Rosenberg Journal: Circulation Date: 2012-01-04 Impact factor: 29.690
Authors: Lauren A Wise; Julie R Palmer; Donna Spiegelman; Bernard L Harlow; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg Journal: Epidemiology Date: 2005-05 Impact factor: 4.822
Authors: Yvette C Cozier; Julie R Palmer; Nicholas J Horton; Lisa Fredman; Lauren A Wise; Lynn Rosenberg Journal: Am J Public Health Date: 2007-02-28 Impact factor: 9.308
Authors: Mette Sørensen; Barbara Hoffmann; Martin Hvidberg; Matthias Ketzel; Steen Solvang Jensen; Zorana Jovanovic Andersen; Anne Tjønneland; Kim Overvad; Ole Raaschou-Nielsen Journal: Environ Health Perspect Date: 2012-01-03 Impact factor: 9.031
Authors: Zorana J Andersen; Ole Raaschou-Nielsen; Matthias Ketzel; Steen S Jensen; Martin Hvidberg; Steffen Loft; Anne Tjønneland; Kim Overvad; Mette Sørensen Journal: Diabetes Care Date: 2011-11-10 Impact factor: 19.112
Authors: Patricia F Coogan; Laura F White; Jeffrey Yu; Robert D Brook; Richard T Burnett; Julian D Marshall; Traci N Bethea; Lynn Rosenberg; Michael Jerrett Journal: Am J Hypertens Date: 2017-04-01 Impact factor: 2.689
Authors: Laura F White; Michael Jerrett; Jeffrey Yu; Julian D Marshall; Lynn Rosenberg; Patricia F Coogan Journal: Am J Prev Med Date: 2016-04-13 Impact factor: 5.043
Authors: Mei Yang; Han Cheng; Chaowei Shen; Jie Liu; Hongkai Zhang; Jiyu Cao; Rui Ding Journal: Environ Sci Pollut Res Int Date: 2019-12-06 Impact factor: 4.223
Authors: Patricia F Coogan; Laura F White; Jeffrey Yu; Richard T Burnett; Julian D Marshall; Edmund Seto; Robert D Brook; Julie R Palmer; Lynn Rosenberg; Michael Jerrett Journal: Environ Res Date: 2016-04-25 Impact factor: 6.498
Authors: Jacob K Kresovich; Zhou Zhang; Fang Fang; Yinan Zheng; Marco Sanchez-Guerra; Brian T Joyce; Jia Zhong; Yana Chervona; Sheng Wang; Dou Chang; John P McCracken; Anaite Díaz; Matteo Bonzini; Michele Carugno; Petros Koutrakis; Choong-Min Kang; Shurui Bian; Tao Gao; Hyang-Min Byun; Joel Schwartz; Andrea A Baccarelli; Lifang Hou Journal: Biomarkers Date: 2017-07-26 Impact factor: 2.658